How would you approach a patient with a history of ulcerative colitis on infliximab infusions with stable small pulmonary nodules and nasal rash, biopsy with granulomatous dermatitis?

How often is it that patients would develop cutaneous sarcoidosis while already being treated with TNFi? Should the next step be biopsy of pulmonary nodule to confirm pulmonary sarcoidosis?